Applied Genetic Technologies Corporation Debt to Equity Ratio 2014-2022 | AGTC
Current and historical debt to equity ratio values for Applied Genetic Technologies Corporation (AGTC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Applied Genetic Technologies Corporation debt/equity for the three months ending September 30, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-09-30 |
$0.04B |
$0.02B |
2.25 |
2022-06-30 |
$0.04B |
$0.03B |
1.26 |
2022-03-31 |
$0.04B |
$0.05B |
0.85 |
2021-12-31 |
$0.04B |
$0.05B |
0.79 |
2021-09-30 |
$0.04B |
$0.07B |
0.59 |
2021-06-30 |
$0.04B |
$0.09B |
0.48 |
2021-03-31 |
$0.03B |
$0.10B |
0.34 |
2020-12-31 |
$0.03B |
$0.04B |
0.73 |
2020-09-30 |
$0.03B |
$0.06B |
0.52 |
2020-06-30 |
$0.03B |
$0.07B |
0.41 |
2020-03-31 |
$0.02B |
$0.09B |
0.24 |
2019-12-31 |
$0.02B |
$0.06B |
0.37 |
2019-09-30 |
$0.02B |
$0.07B |
0.25 |
2019-06-30 |
$0.01B |
$0.08B |
0.17 |
2019-03-31 |
$0.01B |
$0.09B |
0.14 |
2018-12-31 |
$0.03B |
$0.08B |
0.42 |
2018-09-30 |
$0.04B |
$0.08B |
0.49 |
2018-06-30 |
$0.02B |
$0.10B |
0.20 |
2018-03-31 |
$0.02B |
$0.11B |
0.20 |
2017-12-31 |
$0.02B |
$0.11B |
0.18 |
2017-09-30 |
$0.02B |
$0.12B |
0.20 |
2017-06-30 |
$0.03B |
$0.12B |
0.28 |
2017-03-31 |
$0.04B |
$0.12B |
0.34 |
2016-12-31 |
$0.05B |
$0.12B |
0.41 |
2016-09-30 |
$0.06B |
$0.11B |
0.52 |
2016-06-30 |
$0.07B |
$0.11B |
0.65 |
2016-03-31 |
$0.08B |
$0.11B |
0.79 |
2015-12-31 |
$0.09B |
$0.10B |
0.92 |
2015-09-30 |
$0.11B |
$0.10B |
1.16 |
2015-06-30 |
$0.01B |
$0.09B |
0.05 |
2015-03-31 |
$0.00B |
$0.09B |
0.04 |
2014-12-31 |
$0.00B |
$0.10B |
0.03 |
2014-09-30 |
$0.00B |
$0.10B |
0.03 |
2014-06-30 |
$0.00B |
$0.08B |
0.03 |
2014-03-31 |
$0.00B |
$0.03B |
0.10 |
2013-12-31 |
$0.00B |
|
0.00 |
2013-09-30 |
$0.00B |
|
0.00 |
2013-03-31 |
$0.00B |
|
0.00 |